Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET

NCT05420636 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Closed to accrual due to low probability of successful outcomes

Conditions

Small-cell Lung Cancer
Neuroendocrine Carcinoma

Interventions

DRUG: Iadademstat
DRUG: Paclitaxel

Sponsor

Fox Chase Cancer Center

Collaborators

[object Object]